Copyright
©The Author(s) 2024.
World J Gastroenterol. May 21, 2024; 30(19): 2538-2552
Published online May 21, 2024. doi: 10.3748/wjg.v30.i19.2538
Published online May 21, 2024. doi: 10.3748/wjg.v30.i19.2538
Table 5 Serum lipase and amylase levels according to the presence of complications in patients with non-pancreatic hyperlipasemia (n = 401)
No. of patients | Lipase (U/L) | Amylase (U/L) | |||
Median | IQR | Median | IQR | ||
No complications | 239 | 264 | 229-428 | 159 | 106-226 |
Sepsis at all | 111 | 425 | 263-651 | 216 | 112-343 |
AKI at all | 133 | 398 | 259-625 | 190 | 99-335 |
AKI or sepsis | 80 | 282 | 242-527 | 209 | 125-353 |
Sepsis and AKI | 82 | 447 | 275-667 | 220 | 128-344 |
P value | P value | ||||
None/sepsis at all | < 0.001 | < 0.001 | |||
None/AKI at all | < 0.001 | 0.003 | |||
None/one (AKI or sepsis) | 0.042 | 0.009 | |||
None/both (sepsis and AKI) | < 0.001 | 0.001 |
- Citation: Feher KE, Tornai D, Vitalis Z, Davida L, Sipeki N, Papp M. Non-pancreatic hyperlipasemia: A puzzling clinical entity. World J Gastroenterol 2024; 30(19): 2538-2552
- URL: https://www.wjgnet.com/1007-9327/full/v30/i19/2538.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i19.2538